主页文献库搜索
Early switch to a docetaxel-cisplatin (DP) doublet allows higher conversion t...

Moscetti(L),Nelli(F),de Pasquale Ceratti(A... J Clin Oncol 0000-00-00

...mos., respectively. The 1-yr survival was 52%. Main toxicity (G3/4) with sequential DP was greater than with GP, includi...

Phase II trial evaluating combination, weekly gemcitabine and docetaxel in pr...

Huang(C H),Langer(C J),Millenson(M M),Sher... J Clin Oncol 0000-00-00

...mos, and median survival to date exceeds 6 mos.,Combination weekly docetaxel and gemcitabine in the salvage setting post...

Phase II study of a combination of radiofrequency ablation (RFA) and systemic...

Burkart(C),Raible(A),Fuchs(M),Bokemeyer(C)... J Clin Oncol 0000-00-00

...mos. AJCC classification at initial diagnosis: stage II/III/IV 4/4/5. Median no. of LM: 3 (range, 1 - 5), size range 7 -...

Prognostic factors for long term survival in patients with metastatic sarcoma...

Scurr(M),Al-Muderis(O),Karup-Hansen(A),Har... J Clin Oncol 0000-00-00

...mos (range; 1-400 mos), for those that survived ≥ 5yrs the median survival was 91.5 mos. Significant variables predictiv...

Weekly administration of 5-fluorouracil (5-FU), folinic acid (FA), oxaliplati...

Harba(A),Peinert(S),Grothe(W),Jordan(K),Ke... J Clin Oncol 0000-00-00

...mos for all and 8.5 [1-26] mos for CRC pts, respectively. Median OS was 13 [1-54] mos for all and 15.5 [1-54] mos for CR...

Safety, tolerability and pharmacokinetics of oral administration of GW786034 ...

Hurwitz(H),Dowlati(A),Savage(S),Fernando(N... J Clin Oncol 0000-00-00

...most frequent drug related AEs were NCI CTC2, Gr 1 and 2: nausea (Gr 1/2 n=15, Gr 3 n=1), diarrhea (Gr 1/2 n=15), fatigu...

A phase I/II study of Xcellerated T Cells in patients with chronic lymphocyti...

Kipps(T J),Wierda(W G),Castro(J E),Keating... J Clin Oncol 0000-00-00

...mos (range: 5.8-11.0) following the 1st infusion. The 2nd infusions were well-tolerated, with no SAEs reported. 4 of 5 p...

Plasmon-Enhanced Photoelectrical Hydrogen Evolution on Monolayer MoS Decorate...

Cui(Jiabin),Jiang(Rui),Lu(Wenli),Xu(Suying... Small 0000-00-00

...MoS on the Cu S-Au hetero-nanoparticle for hydrogen evolution reaction (HER). The plasmonic NCs dramatically improve the...

Results of total therapy 2 (TT 2), a phase III randomized trial, to determine...

Barlogie(B),Tricot(G),Shaughnessy(J),Rasmu... J Clin Oncol 0000-00-00

...mos (range 9-73). Following 4 cycles of intensive induction chemotherapy, 85% completed 1st and 67% 2nd autotransplant w...

Circulating plasma cells detected by flow cytometry as a predictor of surviva...

Nowakowski(G S),Witzig(T E),Dingli(D),Trac... J Clin Oncol 0000-00-00

...most clinical laboratories. Therefore, we investigated the prognostic significance of circulating PC detected by flow cy...

上一页 689 690 691 692 693 694 695 696 697 下一页 693 / 共 704

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]